Growth Metrics

ClearPoint Neuro (CLPT) EBT Margin (2011 - 2026)

ClearPoint Neuro recorded quarterly EBT Margin of 78.69% in Q1 2026, down 5.27% quarter-over-quarter from 74.76% in Q4 2025, and down 789.0% year-over-year from 11.42% in Q1 2025.

ClearPoint Neuro's EBT Margin history runs 15 years deep, the most recent figure standing at 78.69% for Q1 2026.

  • In Q1 2026, EBT Margin fell 789.0% year-over-year to 78.69%; the TTM figure through Mar 2026 stood at 71.46% (down 700.0% YoY), while the FY2025 annual figure was 68.93%, down 872.0% from the prior year.
  • EBT Margin came in at 78.69% for Q1 2026 at ClearPoint Neuro, down from 74.76% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 54.08% in Q1 2024 to a low of 119.85% in Q2 2023.
  • A 5-year average of 76.19% and a median of 73.75% in 2022 frame the typical range for EBT Margin.
  • Across the five-year window, EBT Margin slumped 3725 bps in 2023 and soared 6394 bps in 2024, its largest moves.
  • ClearPoint Neuro's EBT Margin stood at 86.37% in 2022, then advanced by 20 bps to 69.1% in 2023, then slipped by 1 bps to 69.72% in 2024, then dropped by 7 bps to 74.76% in 2025, then declined by 5 bps to 78.69% in 2026.
  • According to Business Quant data, EBT Margin over the past three periods registered 78.69%, 74.76%, and 66.39% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.98%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 14.12%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 15.57%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 22.33%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 27.84%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 4.87%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 22.61%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 9.84%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.17%
10 ClearPoint Neuro 375.84 Mn 340.24 Mn 7.76 Mn -78.69%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -78.69%
Dec 31, 2025 -74.76%
Sep 30, 2025 -66.39%
Jun 30, 2025 -63.07%
Mar 31, 2025 -70.81%
Dec 31, 2024 -69.72%
Sep 30, 2024 -61.07%
Jun 30, 2024 -55.90%
Mar 31, 2024 -54.08%
Dec 31, 2023 -69.10%
Sep 30, 2023 -84.99%
Jun 30, 2023 -119.85%
Mar 31, 2023 -105.14%
Dec 31, 2022 -86.37%
Sep 30, 2022 -73.75%
Jun 30, 2022 -82.60%
Mar 31, 2022 -78.91%
Dec 31, 2021 -96.82%
Sep 30, 2021 -88.37%
Jun 30, 2021 -106.86%
Mar 31, 2021 -62.36%
Dec 31, 2020 -66.44%
Sep 30, 2020 -41.86%
Jun 30, 2020 -67.47%
Mar 31, 2020 -65.82%
Dec 31, 2019 21.94%
Sep 30, 2019 -38.38%
Jun 30, 2019 -59.55%
Mar 31, 2019 -49.60%
Dec 31, 2018 -53.46%
Sep 30, 2018 -80.41%
Jun 30, 2018 -114.44%
Mar 31, 2018 -103.15%
Sep 30, 2016 -120.52%
Jun 30, 2016 -216.04%
Mar 31, 2016 -166.51%
Sep 30, 2015 -185.31%
Jun 30, 2015 -10,220.41%
Mar 31, 2015 -332.20%
Dec 31, 2014 -7,979.22%
Sep 30, 2014 -493.64%
Jun 30, 2014 -216.07%
Mar 31, 2014 248.41%
Dec 31, 2013 114.42%
Sep 30, 2013 -6,988.21%
Jun 30, 2013 -462.48%
Mar 31, 2013 -1,764.31%
Dec 31, 2012 -12.16%
Sep 30, 2012 -96.81%
Jun 30, 2012 -403.21%
Mar 31, 2012 -3,208.31%
Dec 31, 2011 -435.44%
Sep 30, 2011 -184.96%
Jun 30, 2011 -2,838.35%
Mar 31, 2011 -289.64%